期刊文献+

ABCA1基因变异与血浆高密度脂蛋白胆固醇水平的关系 被引量:1

Relationship between ATP-binding transporter A1 gene variation and plasma high density lipoprotein cholesterol level
下载PDF
导出
摘要 目的探讨腺苷三磷酸结合盒转运体A1(ATP-binding transporter A1,ABCA1)基因多态性与汉族人群血浆高密度脂蛋白胆固醇(high-density lipoprotein cholesterol,HDL-C)水平的关系。方法采用聚合酶链反应-限制性片段长度多态性分析技术检测376例无血缘关系的正常汉族人ABCA1基因M883I、R1587K和R219K多态性。结果研究人群中KK1587基因型者HDL-C水平明显低于RR1587和RK1587基因型者(P<0.05)。按性别分层后,仅女性KK1587基因型者HDL-C水平低于RR1587和RK1587基因型者(P<0.01)。一般线性模型分析显示,R1587K多态对女性个体HDL-C水平变异的贡献度为2.3%(P<0.01)。结论ABCA1基因M883I和R219K多态与汉族人群HDL-C水平无关,但K1587等位基因以隐性作用方式与女性HDL-C水平降低有关。 Objective To investigate the association between the ATP-binding cassette transporter A1 (ABCA1) gene polymorphisms and plasma high density lipoprotein cholesterol (HDL-C) level in Chinese general population. Methods M883I, R1587K and R219K polymorphisms of the ABCA1 gene were detected by polymerase chain reaction-restriction fragment length polymorphism technique in 376 unrelated Chinese healthy subjects. Results In the study population, the subjects with the KK1587 genotype had markedly lower HDL- C levels than those with RR1587 and RK1587 genotypes (P 〈 0.05). When subgroups were divided by gender, the KK1587 genotype was associated with lower HDL-C levels compared with the RR1587 and RK1587 genotypes only in women (P 〈0.01 ). Moreover, the general linear model showed that R1587K polymorphism led to 2.3% of the variation in HDL-C levels in women studied (P 〈 0. 01 ). Conclusion M883I and R219K polymorphisms of the ABCA1 gene are not correlated with HDL-C level in Chinese population, but the recessive K1587 allele may be involved in the decreased level of HDL-C in women.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2007年第24期2347-2349,共3页 Journal of Third Military Medical University
基金 四川省教育厅青年基金(2006B084)~~
关键词 腺苷三磷酸结合盒转运体A1基因 冠状动脉粥样硬化性心脏病 高密度脂蛋白胆固醇 ATP-binding cassette transporter A1 gene coronary heart disease high-density lipoprotein cholesterol
  • 相关文献

参考文献7

  • 1Wilson P W, Abbott R D, Castelli W P. High density lipoprotein cholesterol and mortality. The Framingham Heart Study[ J]. Arteriosclerosis, 1988, 8(6) : 737 -741.
  • 2Brooks-Wilson A, Marcil M, Clee S M, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [ J ]. Nat Genet, 1999, 22(4) : 336 -345.
  • 3Singaraja R R, Brunham L R, Visscher H, et al. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene[ J]. Arterioscler Thromb Vasc Biol, 2003, 23(8) : 1322 - 1332.
  • 4Tregouet D A, Ricard S, Nicaud V, et al. In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction [ J ]. Arterioscler Thromb Vasc Biol, 2004, 24 (4) : 775 -781.
  • 5Clee S M, Zwinderman A H, Engert J C, et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease[J]. Circulation, 2001, 103(9) : 1198 - 1205.
  • 6王旭东,傅研,姜惠杰.冠心病患者ABCA1基因R219K多态性分析[J].临床心血管病杂志,2004,20(4):215-218. 被引量:12
  • 7Frikke-Schmidt R, Nordestgaard B G, Jensen G B, et al. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population[J]. J Clin Invest, 2004, 114(9) : 1343 -1353.

二级参考文献8

  • 1Marcil M,Brooks-Wilson A,Clee SM,et al.Mutations in the ABCA1 gene in familial HDL deficiency with defective cholesterol efflux[].The Lancet.1999
  • 2Goldbourt U,Yaari S,Medalie JH.Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality.A 21-year follow-up of 8 000 men[].Arteriosclerosis and Thrombosis.1997
  • 3McNeish J,Aiello RJ,Guyot D,et al.High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1[].Proceedings of the National Academy of Sciences of the United States of America.2000
  • 4Susanne M,Clee BSC,Aeiko H,etal.Common genetic variation in ABCA1 is associated with altered lipoprotein levels and amodified risk for coronary artery disease[].Circulation.2001
  • 5Lawn RM,,W ade DP,GarvinMR, et al.The Tangier d isease gene productABC1 controls the cellular apolipoprotein-med iated lipid removal pathway[ J][].The Journal of Clinical Investigation.1999
  • 6BrooksWilsonA,MarcilM,CleeSM ,etal.MutationsinABCA1inTangierdiseaseandfamilialhigh densitylipoproteindeficiency[].Nature Genetics.1999
  • 7LangmannT,KluckenJ,ReilM ,etal.MolecularcloningofthehumanATP bindingcassettetransporter(hABC1):evi denceforsterol dependentregulationinmacrophages[].BiochimBiophysResCommun.1999
  • 8TallAR.MetabolicandgeneticcontrolofHDLcholesterollevels[].JInternMed.1992

共引文献11

同被引文献10

  • 1Makishima M. Nuclear receptors as targets for drug development : regulation of cholesterol and bile acid metabolism by nuclear receptors [ J ]. J Pharmacol Sci, 2005, 97(2) : 177 - 183.
  • 2He F, Li J, Mu Y, et al. Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells [ J ]. Circ Res, 2006, 98 (2) : 192 - 199.
  • 3Lu T T, Makishima M, Repa J J, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors [ J ]. Mol Cell, 2000, 6(3) : 507 -515.
  • 4Izem L, Morton R E. Molecular cloning of hamster lipid transfer inhibitor protein ( apolipoprotein F) and regulation of its expression by hyperlipidemia[ J]. J Lipid Res, 2009, 50(4) : 676 -684.
  • 5Shah P K. Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease[ J]. Eur Heart J, 2007, 28 (1): 5 -12.
  • 6Koren E, McConathy W J, Alaupovic P. Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma [ J]. Biochemistry, 1982, 21 (21) : 5347 - 5351.
  • 7Wang X, Driscoll D M, Morton R E. Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity With apolipoprotein F[J]. J Biol Chem, 1999, 274(3): 1814-1820.
  • 8Morton R E, Gnizak H M, Greene D J, et al. Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects[J]. J Lipid Res, 2008, 49( 1 ) : 127 - 135.
  • 9Paromov V M, Morton R E. Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP) [J]. J Biol Chem, 2003, 278(42) : 40859 -40866.
  • 10董金瑜,刘红,彭家和,张艳,王强,李良鹏,王永超,江渝.法尼酯X受体可下调肝细胞中肝型脂肪酸结合蛋白的表达[J].第三军医大学学报,2010,32(5):458-461. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部